Kim De Veirman Selected Research

Paraproteins

1/2022

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim De Veirman Research Topics

Disease

24	Neoplasms (Cancer) 01/2024 - 01/2014
23	Multiple Myeloma 01/2024 - 01/2013
3	Neoplasm Metastasis (Metastasis) 11/2019 - 06/2014
2	Hypoxia (Hypoxemia) 01/2023 - 02/2022
2	Bone Resorption 01/2023 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2019
2	Lymphoma (Lymphomas) 11/2019 - 01/2019
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2019 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2019 - 01/2019
2	Inflammation (Inflammations) 10/2017 - 12/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023
1	Residual Neoplasm 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2013

Drug/Important Bio-Agent (IBA)

7	Bortezomib (Velcade)FDA Link 01/2023 - 10/2017
5	CytokinesIBA 10/2017 - 01/2013
4	Single-Domain AntibodiesIBA 01/2024 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
3	venetoclaxIBA 12/2023 - 01/2019
3	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2021
3	Histone Deacetylase InhibitorsIBA 01/2018 - 05/2013
2	Calgranulin BIBA 12/2023 - 10/2017
2	Proteasome InhibitorsIBA 01/2023 - 11/2020
2	Monoclonal AntibodiesIBA 01/2022 - 01/2022
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2019 - 11/2018
2	Anaphase-Promoting Complex-CyclosomeIBA 01/2019 - 01/2016
2	Vorinostat FDA Link 12/2013 - 05/2013
1	Chimeric Antigen ReceptorsIBA 01/2024
1	AntigensIBA 01/2024
1	S-Adenosylmethionine (Ademetionine)IBA 07/2023
1	Methionine AdenosyltransferaseIBA 07/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Sialic AcidsIBA 01/2023
1	SialyltransferasesIBA 01/2023
1	syrosingopineIBA 01/2023
1	tasquinimodIBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Drug CombinationsIBA 01/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023
1	LigandsIBA 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Pargyline (Pargyline Hydrochloride)FDA Link 02/2022
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	delta-1-pyrroline-5-carboxylateIBA 02/2022
1	Proline (L-Proline)FDA Link 02/2022
1	ParaproteinsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	Complement C3a (Complement 3a)IBA 05/2021
1	Actinium-225IBA 01/2021
1	CaspasesIBA 11/2019
1	Phosphotransferases (Kinase)IBA 11/2019
1	1- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA 11/2019
1	Axl Receptor Tyrosine KinaseIBA 11/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	GW 4869IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	MP0250IBA 03/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018
1	ChromatinIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	EnzymesIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	trametinibIBA 01/2018
1	ABR-238901IBA 10/2017
1	S100 Proteins (S 100 Protein)IBA 10/2017
1	AntibodiesIBA 04/2015
1	Fluorouracil (Carac)FDA LinkGeneric 04/2015
1	ChemokinesIBA 06/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2013

Therapy/Procedure

9	Therapeutics 12/2023 - 01/2018
3	Immunotherapy 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 11/2019
2	Precision Medicine 01/2022 - 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Radioimmunotherapy 01/2022
1	Radiotherapy 01/2022
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2022